2021 annual financial data
China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares 2021 Net margin
China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares 2021 net margin with…
Direct answer
Net margin was -57.52%.
Operating income was -2,197,076 USD and net income was -2,748,183 USD.
Operating cash flow was -1,316,561 USD.
Get free China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,777,573 USD
- Operating income
- -2,197,076 USD
- Net income
- -2,748,183 USD
- Operating cash flow
- -1,316,561 USD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares financial years